IV to Oral Phenytoin Conversion
When converting from IV to oral phenytoin, use the same total daily dose without adjustment, as oral phenytoin capsules are approximately 90% bioavailable and this difference is clinically insignificant. 1
Direct Conversion Approach
The FDA labeling explicitly states that IV phenytoin can be substituted for oral phenytoin at the same total daily dose 1. This 1:1 conversion is appropriate because:
- Phenytoin capsules are ~90% bioavailable orally
- IV phenytoin is 100% bioavailable
- The modest increase in serum concentrations when switching from oral to IV (due to the 10% bioavailability difference) works in reverse when going IV to oral, creating a built-in safety margin 1
Practical Implementation
Dosing Schedule
- Administer oral phenytoin every 6-8 hours after the loading dose phase 1
- Maintain the same total daily dose that was being given IV
- Extended-release capsules may allow once-daily dosing in stable patients
Critical Monitoring Points
Monitor serum phenytoin levels closely during the transition because:
- Individual bioavailability varies (research shows range of 57.7-85.6% in some studies, though FDA data suggests ~90%) 2
- Therapeutic range is narrow (10-20 mcg/mL total; 1-2 mcg/mL unbound) 1
- Phenytoin exhibits saturable (Michaelis-Menten) kinetics, making small dose changes potentially significant
Special Populations Requiring Dose Adjustment
In patients with hypoalbuminemia, renal disease, or hepatic disease:
- Monitor unbound (free) phenytoin concentrations rather than total levels 1
- The fraction of unbound phenytoin increases in these conditions
- Standard total levels may be misleadingly low while free levels are therapeutic or toxic
Important Caveats
Formulation Considerations
- Oral suspension and extended-release capsules are bioequivalent for total drug exposure 3
- However, extended-release capsules reach peak levels much later (8-13 hours) compared to suspension 4
- Do not use oral loading if rapid therapeutic levels are needed - it takes >5 hours to reach therapeutic concentrations 5, 6
When NOT to Convert
The guideline evidence suggests oral phenytoin should be used whenever possible due to lower adverse event rates compared to IV administration 5, 6. However, maintain IV route if:
- Patient cannot take oral medications
- Rapid achievement of therapeutic levels is required
- Active seizures are occurring
Serum Level Timing
- Obtain trough levels just before the next scheduled dose for therapeutic monitoring 1
- Allow 5-7 days to reach steady state before assessing maintenance dosing adequacy
- Earlier levels may be misleading due to phenytoin's long and variable half-life (mean 17-19 hours, but can be much longer) 2, 7
The conversion is straightforward: same total daily dose, divided every 6-8 hours orally, with close monitoring of serum levels to ensure therapeutic range is maintained.